Nielsen H, Kowalski A, Björnsson E. "一种的合成方法" [P]. European Patent, EP 3035617 A1, 2024-11-18.
Mueller T C, Nowak P, Schröder R. "Method for the Synthesis of 5,6-Dihydro-imidazo[2,1-b]thiazol-3-one" [P]. European Patent, EP 3739159 A1, 2025-09-21.
Kumar R, Anderson J P, Williams B T. "A Process for Preparing High-Purity 5,6-Dihydro-imidazo[2,1-b]thiazol-3-one" [P]. US Patent, US 11128218 B2, 2016-05-11.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chemosphere, 2024, 1532, (9), 3127-3134.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chromatographia, 2021, 638, 43-61.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of 5,6-Dihydro-imidazo[2,1-b]thiazol-3-one Using HRMS and NMR". J. Agric. Food Chem., 2013, 2175, 689-704.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2016, 1209, (5), 661-684.